Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia-Reference-Cited by-同舟云学术

Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia

Published:1998-09 Issue:3 Volume:15 Page:141-144
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Nowrousian MR

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02821932.pdf

Reference32 articles.

1. Skillings JRet al. The frequency of red cell transfusion for anaemia in patients receiving chemotherapy. A retrospective cohort study.Am J Clin Oncol 1993;16: 22–25.

2. Skillings JRet al. An epidemiological review of anaemia in cancer chemotherapy in Canada.Eur J Cancer 1995;31A (Suppl 5): S183.

3. Abels Ret al. Transfusion practice in advanced cancer patients.Blood 1991;78 (Suppl 1): 474a.

4. Nowrousian MRet al. Pathophysiology of cancer-related anemia. In: Smyth JF, Boogaerts MA, Ehmer BRM (eds).rhErythropoietin in Cancer Supportive Treatment, Marcel Dekker: New York, 1996, pp. 13–34.

5. Mohandas K, Aledort L. Transfusion requirements, risks, and costs for patients with malignancy.Transfusion 1995;35: 427–430.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant blood products and therapeutic enzymes: An update;The Future of Pharmaceutical Product Development and Research;2020

2. Aspects of the pathogenesis of anemia in cancer patients;Kazan medical journal;2019-12-09

3. Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials;Journal of Comparative Effectiveness Research;2013-01

4. CLINICAL PRACTICE OF RECOMBINANT HUMAN ERYTHROPOETIN IN CANCER RELATED ANEMIA;International journal of pharmaceutical sciences and research;2011-04-01

5. Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients;Clinical Hemorheology and Microcirculation;2010